High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)

Cresswell, Fiona; Ssebambulidde, Kenneth; Grint, Daniel; te Brake, Lindsey; Musabire, Abdul; Atherton, Rachel; Tugume, Lillian; Muzoora, Conrad; Lukande, Robert; Lamorde, Mohammed; +4 more... Aarnoutse, Rob; Meya, David; Boulware, David; Elliott, Alison; (2018) High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study). Wellcome open research, 3. p. 83. ISSN 2398-502X DOI: https://doi.org/10.12688/wellcomeopenres.14691.1

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.12688/wellcomeopenres.14691.1

Abstract

Share

Download

Filename: Creswell_etal_2018_High_dose_oral_and_intravenous_rifampicin.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar